Reduced cardiolipin content decreases respiratory chain capacities and increases ATP synthesis yield in the human HepaRG cells

Autor: Peyta, Laure, Jarnouen, Kathleen, Pinault, Michelle, Guimaraes, Cyrille, Pais de Barros, Jean-Paul, Chevalier, Stephan, Dumas, Jean-François, Maillot, François, Hatch, Grant M., Loyer, Pascal, Servais, Stephane

Publikováno v: In BBA - Bioenergetics April 2016 1857(4):443-453

Implication of liver cardiolipins in mitochondrial energy metabolism disorder in cancer cachexia

Autor: Dumas, Jean-François, Peyta, Laure, Couet, Charles, Servais, Stéphane

Publikováno v: In Biochimie January 2013 95(1):27-32

Defects in mitophagy promote redox-driven metabolic syndrome in the absence of TP53INP1

Autor: Seillier, Marion, Pouyet, Laurent, N Guessan, Prudence, Nollet, Marie, Capo, Florence, Guillaumond, Fabienne, Peyta, Laure, Dumas, Jean-Francois, Varrault, Annie, Bertrand, Gyslaine, Bonnafous, Stephanie, Tran, Albert, Meur, Gargi, Marchetti, Piero, Magalie Ravier, Dalle, Stephane, Gual, Philippe, Muller, Dany, Rutter, Guy A., Servais, Stephane, Iovanna, Juan L., Carrier, Alice

Publikováno v: EMBO Molecular Medicine
EMBO Molecular Medicine, Wiley Open Access, 2015, pp.802-818. ⟨10.15252/emmm.201404318⟩
ResearcherID
EMBO Molecular Medicine, Wiley Open Access, 2015, 7, pp.802-818. ⟨10.15252/emmm.201404318⟩
EMBO Molecular Medicine, 2015, pp.802-818. ⟨10.15252/emmm.201404318⟩

International audience; The metabolic syndrome covers metabolic abnormalities including obesity and type 2 diabetes (T2D). T2D is characterized by insulin resistance resulting from both environmental and genetic factors. A genome-wide association stu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::62f23e8d3370580f2ad330e32c0e5f0e
https://hal-amu.archives-ouvertes.fr/hal-01208177/document

Defects in mitophagy promote redox-driven metabolic syndrome in the absence of TP53INP1.

Autor: Seillier M; Inserm, U1068, CRCM, Marseille, France Institut Paoli-Calmettes, Marseille, France Aix-Marseille Université, Marseille, France CNRS, UMR7258, CRCM, Marseille, France., Pouyet L; Inserm, U1068, CRCM, Marseille, France Institut Paoli-Calmettes, Marseille, France Aix-Marseille Université, Marseille, France CNRS, UMR7258, CRCM, Marseille, France., N'Guessan P; Inserm, U1068, CRCM, Marseille, France Institut Paoli-Calmettes, Marseille, France Aix-Marseille Université, Marseille, France CNRS, UMR7258, CRCM, Marseille, France., Nollet M; Inserm, U1068, CRCM, Marseille, France Institut Paoli-Calmettes, Marseille, France Aix-Marseille Université, Marseille, France CNRS, UMR7258, CRCM, Marseille, France., Capo F; Inserm, U1068, CRCM, Marseille, France Institut Paoli-Calmettes, Marseille, France Aix-Marseille Université, Marseille, France CNRS, UMR7258, CRCM, Marseille, France., Guillaumond F; Inserm, U1068, CRCM, Marseille, France Institut Paoli-Calmettes, Marseille, France Aix-Marseille Université, Marseille, France CNRS, UMR7258, CRCM, Marseille, France., Peyta L; Inserm, U1069 Nutrition, Croissance et Cancer (N2C), Tours, France., Dumas JF; Inserm, U1069 Nutrition, Croissance et Cancer (N2C), Tours, France., Varrault A; CNRS, UMR5203, Inserm, U661 Universités de Montpellier 1 & 2, IGF, Montpellier, France., Bertrand G; CNRS, UMR5203, Inserm, U661 Universités de Montpellier 1 & 2, IGF, Montpellier, France., Bonnafous S; Inserm, U1065, C3M Team 8 'Hepatic Complications in Obesity', Nice, France Université de Nice-Sophia-Antipolis, Nice, France Centre Hospitalier Universitaire de Nice, Pôle Digestif Hôpital L'Archet, Nice, France., Tran A; Inserm, U1065, C3M Team 8 'Hepatic Complications in Obesity', Nice, France Université de Nice-Sophia-Antipolis, Nice, France Centre Hospitalier Universitaire de Nice, Pôle Digestif Hôpital L'Archet, Nice, France., Meur G; Cell Biology, Department of Medicine, Imperial College, London, UK., Marchetti P; Islet Cell Laboratory, University of Pisa - Cisanello Hospital, Pisa, Italy., Ravier MA; CNRS, UMR5203, Inserm, U661 Universités de Montpellier 1 & 2, IGF, Montpellier, France., Dalle S; CNRS, UMR5203, Inserm, U661 Universités de Montpellier 1 & 2, IGF, Montpellier, France., Gual P; Inserm, U1065, C3M Team 8 'Hepatic Complications in Obesity', Nice, France Université de Nice-Sophia-Antipolis, Nice, France Centre Hospitalier Universitaire de Nice, Pôle Digestif Hôpital L'Archet, Nice, France., Muller D; CNRS, UMR5203, Inserm, U661 Universités de Montpellier 1 & 2, IGF, Montpellier, France., Rutter GA; Cell Biology, Department of Medicine, Imperial College, London, UK., Servais S; Inserm, U1069 Nutrition, Croissance et Cancer (N2C), Tours, France., Iovanna JL; Inserm, U1068, CRCM, Marseille, France Institut Paoli-Calmettes, Marseille, France Aix-Marseille Université, Marseille, France CNRS, UMR7258, CRCM, Marseille, France., Carrier A; Inserm, U1068, CRCM, Marseille, France Institut Paoli-Calmettes, Marseille, France Aix-Marseille Université, Marseille, France CNRS, UMR7258, CRCM, Marseille, France alice.carrier@inserm.fr.

Publikováno v: EMBO molecular medicine [EMBO Mol Med] 2015 Jun; Vol. 7 (6), pp. 802-18.